Who owns CITIUS ONCOLOGY INC?
- Ticker: CTOR
- CUSIP Number: 17331y109
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Citius Oncology stock
Who bought or sold CITIUS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 7.7M | $16M | 100% | Sep 2025 |
|
| Vanguard Group | 597k | $597k | 231% | Dec 2025 |
|
| Geode Capital Management | 220k | $220k | 32% | Dec 2025 |
|
| OMERS Administration Corporation | 105k | $105k | 100% | Dec 2025 |
|
| IFP Advisors | 87k | $87k | 163% | Dec 2025 |
|
| XTX Topco | 74k | $74k | -42% | Dec 2025 |
|
| Northern Trust | 46k | $46k | 110% | Dec 2025 |
|
| State Street Corporation | 43k | $43k | 0% | Dec 2025 |
|
| BlackRock | 22k | $22k | 100% | Dec 2025 |
|
| UBS Group | 22k | $22k | 38925% | Dec 2025 |
|
| Citadel Advisors | 18k | $36k | 100% | Sep 2025 |
|
| Two Sigma Securities | 13k | $13k | 100% | Dec 2025 |
|
| Arkadios Wealth Advisors | 12k | $12k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 11k | $11k | -3% | Dec 2025 |
|
| Versant Capital Management | 1.5k | $1.5k | 100% | Dec 2025 |
|
| Farther Finance Advisors | 3.00 | $3.000000 | 0% | Dec 2025 |
|
Who sold out of Citius Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 56k | $114k |
| Tower Research Capital | Sep 2025 | 12k | $24k |